Md. biopharm shows profit, continues studies of cancer drug

Rexahn Pharmaceuticals Inc., a Rockville biopharmaceutical company, had a profit in its second quarter because of accounting adjustments resulting from a change in stock price. Taking into account an upward adjustment of $5.5 million in an unrealized gain on the fair value of warrants, Rexahn’s profit was just under $1 million in the quarter, or 4 …



Author: Baltimore Checkbook

Best in consumer news and deals in Baltimore, MD.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s